Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Cancer Prev Res (Phila). 2022 Mar 1;15(3):193–201. doi: 10.1158/1940-6207.CAPR-21-0298

Table 1.

Baseline characteristics by randomized group1 (N=50)

DPP-only DPP+HT

N 23 27
Age (years), mean (SD) 61.3 (6.9) 59.5 (5.1)
BMI (kg/m2), mean (SD) 36.1 (5.6) 33.8 (4.7)
BMI category Overweight (BMI=27–29.9 kg/m2) 2 (8.7%) 3 (11.1%)
Obese class I (BMI=30–34.9 kg/m2) 11 (47.8%) 16 (59.3%)
Obese class II and III (BMI≥35 kg/m2) 10 (43.5%) 8 (29.6%)
Taking hormone therapy 1 (4.3%) 5 (18.5%)
Taking metformin 0 (0%) 1 (3.7%)
Ethnicity Non-Hispanic 21 (91.3%) 26 (96.3%)
Hispanic 0 (0%) 1 (3.7%)
Not reported 2 (8.6%) 0 (0%)
Race White 16 (69.6%) 25 (92.6%)
Black 6 (26.1%) 2 (7.4%)
Other 1 (4.3%) 0 (0%)
Education Any college 22 (95.7%) 22 (81.5%)
No college 1 (4.3%) 5 (19.2)
Employed 10 (43.5%) 16 (59.3%)
Partnered 17 (73.9%) 22 (81.5%)
Household income <$75,000 5 (21.7%) 7 (25.9%)
≥$75,000 13 (56.5%) 14 (51.9%)
Not reported 5 (21.7%) 6 (22.2%)
1

Values are number (%) unless otherwise indicated